profit from every ZAR 100 of sales.
ZAR 0ZAR 100
Dis-Chem Pharmacies
ZAR 23.74+0.08% today
-32.4% in 1 year
1-year low ZAR 23.721-year high ZAR 38.19
Trading close to its lowest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average.
0%20% a year
You pay ZAR 20.76 for every ZAR 1 of profit it makes in a year.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Dis-Chem Pharmacies vs. similar companies
Dis-Chem Pharmacies grows in the middle of these 5 and is priced in the middle for its profits.
| Company | Profit from ZAR 100 of sales | Sales growth a year | Price per ZAR 1 of profit |
|---|---|---|---|
| Dis-Chem Pharmacies | 20.8× · Fair price | ||
 JD Health International | 20.7× · Fair price | ||
 Tsuruha Holdings | 26.6× · Fair price | ||
 MatsukiyoCocokara & | 19.6× · Fair price | ||
 Yifeng Pharmacy Chain | 17.9× · Fair price |
AI analysis
An AI analyst reads Dis-Chem Pharmacies's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisNo annual statements on file yet.
Valuation
- 20.8×
- –
- 2.37
- 5.1×
- 0.5×
- 29.5×
- –
- 3.4%
- 4.8%
- –
Profitability
- 22.0%
- -4.2%
- 2.3%
- –
- 11.6%
- 13.3%
- –
- –
- –
- –
Growth
- +9.4%
- +8.8%
- –
- –
- −0.1%
Financial health
- 1.9×
- 1.18
- –
- 3.5×
- 1.11
- –
- –
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Top 24%of 952
Bottom 17%of 883
Top 36%of 576
Bottom 43%of 870
Top 32%of 985
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
0/7Passes 0 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
43No pass
Benjamin Graham
45No pass
Philip Fisher
43No pass
Peter Lynch
32No pass
Joel Greenblatt
32No pass
Charlie Munger
32No pass
Terry Smith
29No pass
Questions about Dis-Chem Pharmacies
Is Dis-Chem Pharmacies a good stock to buy?
A business with weak numbers at a fair price. 0 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Dis-Chem Pharmacies AI analysis
What does Dis-Chem Pharmacies do?
Dis-Chem Pharmacies Limited, together with its subsidiaries, engages in the retail and wholesale of healthcare products and pharmaceuticals in South Africa. The company operates through two segments: Retail and Wholesale. It is in Pharmaceutical Retailers.
Is Dis-Chem Pharmacies stock halal?
Questionable. Dis-Chem Pharmacies sits in a grey zone: its debt is 33% of its market value, between 30% and 33%. How we check
How has Dis-Chem Pharmacies stock done over the past year?
Down 32.4% over the past twelve months, to ZAR 23.74. It traded between ZAR 23.72 and ZAR 38.19 and is 37.8% below its high.
Who are Dis-Chem Pharmacies's competitors?
The largest listed companies in the same industry are JD Health International, Tsuruha Holdings, MatsukiyoCocokara & and Yifeng Pharmacy Chain. The peers table on this page compares their profit, growth and price with Dis-Chem Pharmacies's.
Prices: daily closes to Nov 12, 2026. Fundamentals: company reports via invest-like data.